Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

October 10, 2015 2:54 PM ET


Company Overview of Reaction Biology Corporation

Company Overview

Reaction Biology Corporation operates as a contract research organization that provides in vitro enzyme activity assays for HTS and profiling. It offers products and services in the areas of kinase assay profiling, DUB enzymes, protease profiling and HTS, compound library screening, cell based assays, CYP/hERG assays, epigenetic regulatory enzymes, histone deacetylases, histone acetyltransferases, demethylases, proteins, epigenetic readers, histone methyltransferase profiling and HTS, antibody and protein microarray, custom assay development, oxidoreductase assays, and compound reformatting. It serves various customers, such as pharmaceutical, biotech, government, and academic labs in the Un...

One Great Valley Parkway

Suite 2

Malvern, PA 19355

United States

Founded in 2001





Key Executives for Reaction Biology Corporation

Chief Executive Officer, President, and Director
Age: 59
Scientific Founder, Scientific Advisor and Director
Director of Biochemistry
Director of Epigenetics
Director of Research Services
Compensation as of Fiscal Year 2015.

Reaction Biology Corporation Key Developments

Reaction Biology and Cisbio Bioassays Sign Distribution Agreement

Reaction Biology Corporation announced that it has signed an agreement for Cisbio Bioassays to distribute its epigenetic proteins. RBC manufactures one of the largest collections of recombinant human epigenetic proteins. These proteins modulate genetic function in humans and are the subject of intense research in the pharmaceutical industry to validate them as targets for a new generation of cancer drugs. Cisbio develops and markets a broad selection of assays used worldwide by researchers in drug discovery. The company has recently expanded its product offering with very innovative solutions to assess epigenetic targets such as methyltransferases. The new agreement will give Cisbio worldwide rights to co-market and sell RBC's proteins.

Similar Private Companies By Industry

Company Name Region
SQZ Biotechnologies Company United States
Metrigen, Inc. United States
On Target Laboratories, LLC United States
Abide Therapeutics, Inc. United States
China PharmaHub Corp. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Reaction Biology Corporation, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at